期刊文献+

依卡倍特钠联合治疗糜烂性胃炎的临床观察 被引量:1

Clinical Efficacy of Ecabet Sodium in Treatment of Gastric Ulcer
下载PDF
导出
摘要 目的:观察糜烂性胃炎或胃溃疡应用依卡倍特钠联合标准三联疗法治疗疗效。方法:189例胃镜诊断麋烂性胃炎或胃溃疡合并幽门螺杆菌感染的患者。随机分成治疗组和对照组,在实用奥美拉唑,阿莫西林,克拉霉素的基础上,治疗组加用依卡倍特钠4周,观察两组患者癌状改善情况,治疗结束。观察内镜下胃溃疡或糜烂的愈合情况。结果:治疗1周患者症状缓解程度和溃疡愈合率明显优于对照组。 Objective:To study the effects of ecabet sodium and standard triple therapy in treatment of gastric ulcer. Methods: 189 patients with erodive gastritis or gastric ulcer and Helicobacter pylori infection diagndsed by gasrtoscope were enrolled. All patients were randomized into study group and controlled group.All patients were given Omeprazole, Amoxicillin and Clavithromycin. In addition, the study group was given ecabet sodium for 4-week,Imregimens in symptons were recorded,The cure rate was assessed by endoscopy. Results: The combined therapy of ecabet sodium relieves the gastric pain more rapidly and The cure rate of gastric ulcer than the single fanotidine therapy. Conelusions:Ecabet sodium and standard triple therapy in treatment of gastric ulcer is highly effective.
作者 刘小玲
机构地区 河南宏力医院
出处 《中国医药导刊》 2009年第6期967-968,共2页 Chinese Journal of Medicinal Guide
关键词 依卡倍特钠 胃溃疡 ecabet sodium gastric ulcer
  • 相关文献

参考文献11

  • 1胡伏莲,张万岱,萧树东,胡品津,刘文忠,王继德,徐智民.对幽门螺杆菌若干问题的共识意见(2003·中国)[J].中华全科医师杂志,2005,4(1):33-35. 被引量:43
  • 2王惠吉,于中麟,林三仁,周丽雅,钱家鸣,刘晓红,程留芳,孙国辉,黄乃侠,吕宗舜.依卡倍特钠治疗胃溃疡及胃炎的疗效和安全性[J].中国新药杂志,2005,14(8):1045-1048. 被引量:13
  • 3Kono T, Nomura M, Kasai S, et al. Effect of ecabet sodium enema on midly to moderately active ulcerative proctosigmoiditis: an open-label study . Am J Gastroenterol, 2001; 96(3): 793.
  • 4Pearson JP, RToberts NB. Mucosal protentive effects of ecabet sodium: pepsin inhibition and interaction with mucus. Clin-Sci-(Lond), 2001; 100 (4) :411.
  • 5Katagiri F, Shiga T, Sato Y, et al. Takeyama, -M Comparison of the effects of eyto protective drugs on human plasma adrenocorticotropic hormone and cortisol levels with continual stress exposure. Biol-Pharm-Bul, 2005;28(11): 2146.
  • 6Sasaki K, Lizuka M, Konno S,et al. Ecabet sodium prevents the delay of wound repair in intestinal epithelial cells inTI:Ecabet sodium prevents the delay of wound repair in intestinal epithelial cells induced by hydrogen peroxide. J-Gastroenterol, 2005; 40(5): 474.
  • 7Asada S, Takiuchi H, Tei H, et al. Evaluation of an anti-ulcer drug, Ecaber Sodiun(TA-2711) on covering of the gastric mucosa[J]. Jpn J Clin Exp Med, 1994;71 : 2439-2443.
  • 8Adaehi K, lshihara S, Hashimoto T, et al. Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole- based regimen.Aliment Pharmacol Ther,2001 ; 15(8): 1187-1191.
  • 9张元庆 李娜 韦舒静 等.依幸倍特钠治疗糜烂性胃炎组织学愈合质量的观察[J].当代医学,2007,2:13-15.
  • 10王晓东,李春华.依卡倍特钠联合法莫替丁治疗胃溃疡疗效观察[J].武警医学,2007,18(2):118-120. 被引量:4

二级参考文献13

  • 1王惠吉,于中麟,林三仁,周丽雅,钱家鸣,刘晓红,程留芳,孙国辉,黄乃侠,吕宗舜.依卡倍特钠治疗胃溃疡及胃炎的疗效和安全性[J].中国新药杂志,2005,14(8):1045-1048. 被引量:13
  • 2Inane M, Matsumoto N, Suenaga T, et al. Effects of the antiulcer agent TA-2711 on basal secretion in the human stomach[J]. Prog Med,1991,11:327- 334.
  • 3Misawa T, Chijiiwa Y, Fujishima H, et al. Binding of TA-7211, a novel therapeutic agent for gastric ulcers, to gastric ulcer lesions[ J]. J New Rem Clin ( Shin-yaku to Rinshou ), 1991,40:727 - 732.
  • 4Asada S,Takiuchi H,Tei H, et al. Evaluation of an anti-ulcer drug,Ecabet Sodium(TA-2711) on covering of the gastric mucosa[J]. Jpn J Clin Exp Med,1994,71:2439- 2443.
  • 5Miyoshi A, Goto Y, Sekiguchi T, et al. Early clinical trial of the antiulcer agent TA-7211 for treatment of gastric ulcers [ J ]. Prog Med,1991,11 : 293 - 303.
  • 6Abe S, Hongo M, Yamaguchi N, et al. Studies on gastric mucosal disturbances induced by aspirin in humans-preventive effects of TA-7211 [J]. J New Rent Clin ( Shin-yaku to Rinshou ), 1991,40 : 719 -724.
  • 7Kohli Y, Kato T, suzuki K, et al. Studies on effects of 12-sulfodehydroabietic acid monosodium salt( TA-2711 ) on hexasamine and prostaglandias contents in human gastric mucosa [ J]. Kyoto Pref Univ Med, 1990,99(9) : 1085 - 1090.
  • 8Kono T,Nomura M,Kasai S et al.Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis:an open-label study.Am J Gastroenterol,2001,96(3):793
  • 9Inoue M,Matsumoto N.Suenaga T et al.Effects of the antiulcer agent TA-2711 on basal secretion in the human stomach.Prog Med,1991,11:327
  • 10Pearson JP,Roberts NB.Mucosal protective effects of ecabet sodium:pepsin inhibition and interaction with mucus.Clin-Sci-(Lond),2001,100(4):411

共引文献56

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部